Methyl 6-O-cinnamoyl-α-d-glucopyranoside Ameliorates Acute Liver Injury by Inhibiting Oxidative Stress Through the Activation of Nrf2 Signaling Pathway

Excessive stimulation of hepatotoxins and drugs often lead to acute liver injury, while treatment strategies for acute liver injury have been limited. Methyl 6-O-cinnamoyl-α-d-glucopyranoside (MCGP) is a structure modified compound from cinnamic acid, a key chemical found in plants with significant...

Full description

Bibliographic Details
Main Authors: Chen, T. (Author), Chen, X. (Author), Deng, Y. (Author), Luo, Z. (Author), Mao, L. (Author), Ming, J. (Author), Ren, H. (Author), Sun, W. (Author), Wang, Y. (Author), Xu, Q. (Author), Yan, S. (Author), Zhang, Y. (Author), Zhou, J. (Author), Zhou, Q. (Author)
Format: Article
Language:English
Published: Frontiers Media S.A. 2022
Subjects:
Online Access:View Fulltext in Publisher
LEADER 02791nam a2200349Ia 4500
001 10.3389-fphar.2022.873938
008 220706s2022 CNT 000 0 und d
020 |a 16639812 (ISSN) 
245 1 0 |a Methyl 6-O-cinnamoyl-α-d-glucopyranoside Ameliorates Acute Liver Injury by Inhibiting Oxidative Stress Through the Activation of Nrf2 Signaling Pathway 
260 0 |b Frontiers Media S.A.  |c 2022 
856 |z View Fulltext in Publisher  |u https://doi.org/10.3389/fphar.2022.873938 
520 3 |a Excessive stimulation of hepatotoxins and drugs often lead to acute liver injury, while treatment strategies for acute liver injury have been limited. Methyl 6-O-cinnamoyl-α-d-glucopyranoside (MCGP) is a structure modified compound from cinnamic acid, a key chemical found in plants with significant antioxidant, anti-inflammatory, and antidiabetic effects. In this study, we investigated the effects and underlying mechanisms of MCGP on acetaminophen (APAP)- or carbon tetrachloride (CCl4)-induced acute liver injury. As a result, MCGP inhibited cell death and apoptosis induced by APAP or CCl4, and suppressed the reactive oxygen species (ROS) generation stimulated by H2O2 in liver AML12 cells. In vivo, MCGP alleviated APAP/CCl4-induced hepatic necrosis and resumed abnormal aminotransferase activities and liver antioxidase activities. In addition, MCGP depressed APAP- or CCl4-induced oxidative stress through the suppression of CYP2E1 and activation of nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway. MCGP also enhanced the number of PCNA-positive hepatocytes, increased hepatic PCNA and Bcl-XL, and decreased BAX expression in APAP-/CCl4-intoxicated mice. Furthermore, MCGP activated the GSDMD-N/cleaved caspase 1 pathway. In summary, MCGP might act as a potential therapeutic drug against drug-induced and chemical-induced acute liver injuries, and its underlying mechanisms might engage on the pressing of oxidative stress, refraining of hepatocyte apoptosis, and facilitating of liver regeneration. Copyright © 2022 Xu, Deng, Ming, Luo, Chen, Chen, Wang, Yan, Zhou, Mao, Sun, Zhou, Ren and Zhang. 
650 0 4 |a acute liver injury 
650 0 4 |a hepatocyte apoptosis 
650 0 4 |a liver regeneration 
650 0 4 |a methyl 6-O-cinnamoyl-α-d-glucopyranoside 
650 0 4 |a oxidative stress 
700 1 |a Chen, T.  |e author 
700 1 |a Chen, X.  |e author 
700 1 |a Deng, Y.  |e author 
700 1 |a Luo, Z.  |e author 
700 1 |a Mao, L.  |e author 
700 1 |a Ming, J.  |e author 
700 1 |a Ren, H.  |e author 
700 1 |a Sun, W.  |e author 
700 1 |a Wang, Y.  |e author 
700 1 |a Xu, Q.  |e author 
700 1 |a Yan, S.  |e author 
700 1 |a Zhang, Y.  |e author 
700 1 |a Zhou, J.  |e author 
700 1 |a Zhou, Q.  |e author 
773 |t Frontiers in Pharmacology